Genome Editing ETF
- 933.650
- -11.362-1.20%
Cathie Wood's Ark Invest Trims Tesla Exposure Amid Searing Rally, Sells $21.8M Worth Of Stock — Bets On This AI Medical Company
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Hedge Funds Were Net Buyers of Financials, Healthcare for Week: Goldman Sachs
Continuously High Dispersion in the Markets Could Make It a 'Picker's Market'
ARKK's Holdings Ranked by SA Quant Grades
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
The Most Overbought and Oversold Global Sectors - Utilities Most OB
Why Is Medpace Stock Diving On Tuesday?
Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock
Capitulation in Biotech Is Near, as Well as a Rally – Piper Sandler
Why Recursion Is Getting Love as an AI and Drug Discovery Top Pick
Cassava Sciences Stock Sinks 14% After $40 Million Settlement With SEC
Stocks May Correct in September: Morgan Stanley's Caron
Cathie Wood-Led Ark Invest Went Shopping For AMD, Tesla, Amazon, Coinbase, Robinhood, Meta And Palantir Shares Amid Market Crash On Monday
Tesla Bull Cathie Wood's Ark Invest Sells $7.16M Worth Of EV Maker's Shares After Q2 Earnings Reveal Profits Tanked Sharply
Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates
The Fed's Ambivalence: What Investors Can Expect from Its Dovish Shift